Park Ridge, ILNCT06533098Now EnrollingIRB Ready

Thrombocytopenia, Neonatal Alloimmune Clinical Trial in Park Ridge, IL

Access cutting-edge thrombocytopenia, neonatal alloimmune treatment through this clinical trial at a research site in Park Ridge. Study-provided care at no cost to qualified participants.

Sponsored by Janssen Research & Development, LLC

Quick Self-Assessment

See if you qualify for this Park Ridge location

Preparing your pre-screening questions…

Expert Care in Park Ridge

Access thrombocytopenia, neonatal alloimmune specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related thrombocytopenia, neonatal alloimmune treatment provided free

Apply for This Park Ridge Location

Check if you qualify for this thrombocytopenia, neonatal alloimmune clinical trial in Park Ridge, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Park Ridge

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Park Ridge site if eligible
  4. 4Begin participation

About This Thrombocytopenia, Neonatal Alloimmune Study in Park Ridge

The purpose of this study is to assess the efficacy and safety of nipocalimab in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT).

Sponsor: Janssen Research & Development, LLC

Who Can Participate

Inclusion Criteria

Pregnant and an estimated gestational age (GA) from week 13\
to 18 at visit 1 \*Randomization for high-risk FNAIT participants to occur at GA Week 12
Has a history of greater than or equal to (\>=) 1 prior pregnancy with FNAIT based on medical records including: a) neonatal platelet count less than (\<) 150\*10\^9/Liter with no fetal/neonatal intracranial hemorrhage (ICH) or severe fetal/neonatal hemorrhage (standard-risk) OR b) fetus/neonate with ICH or severe hemorrhage in a fetus/neonate (high-risk)
Current pregnancy with presence of maternal anti-HPA-1a and/or anti-HPA-5b alloantibody and positive fetal HPA-1a and/or HPA-5b genotype as confirmed by cell-free fetal DNA in maternal blood
Health status considered stable by the investigator based on physical examination, medical history, vital signs, 12-lead electrocardiogram (ECG), and clinical laboratory tests performed at screening
For maternal participant and neonate/infant, willing to forego participation in another clinical study of an investigational therapy until the last follow-up visit

Exclusion Criteria

Currently pregnant with multiple gestations (twins or more)
History of severe preeclampsia in a previous pregnancy
History of myocardial infarction, unstable ischemic heart disease, or stroke
Known allergies, hypersensitivity, or intolerance to nipocalimab or its excipients, to IVIG or to prednisone
Has any confirmed or suspected clinical immunodeficiency syndrome or has a family history of congenital or hereditary immunodeficiency unless confirmed absent in the participant

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Park Ridge?

Yes, this clinical trial (NCT06533098) has an active research site in Park Ridge, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Thrombocytopenia, Neonatal Alloimmune Treatment Options in Park Ridge, IL

If you're searching for thrombocytopenia, neonatal alloimmune treatment options in Park Ridge, IL, this clinical trial (NCT06533098) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Park Ridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thrombocytopenia, neonatal alloimmune specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all thrombocytopenia, neonatal alloimmune clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Park Ridge, IL

See all leukemia clinical trials recruiting in Park Ridge — not just this study.

Browse Leukemia Trials in Park Ridge →

Browse More Trials by Condition

Leukemia TrialsMultiple Myeloma TrialsPulmonary Embolism TrialsPremature Birth TrialsThrombocytopenia TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Park Ridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Park Ridge, IL